None listed
Conditions
Interventions
Intervention1: Group I (Valsalva): Donors will be asked to blow into a rubber tubing connected to sphygmomanometer and raise the mercury column up to 30 mmHg for a period of at least 20 sec. after val
Sponsors
Sanjay Gandhi Postgraduate Institute Of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Group II (Control): Will be acting as control and will not perform valsalva. Just after performing valsalva maneuver, phlebotomy would be done with a 16 G intravenous needle (in the antecubital vein) by an expert
Exclusion criteria
Exclusion criteria: Repeated plateletpheresis donors, donors with abnormal skin condition such as scar, infection at the site of proposed needle puncture, scars, eczema, those in whom the venipuncture would be difficult or traumatic (blood extravasation, hematoma, nerve injury, arterial puncture injury, allergy, veinitis, thrombosis, sign and symptom of vasovagal syncope, convulsion, sweating), donor with history of syncope/vasovagal attack, anxiety disorder, donors requiring > 1 attempt for successful intravenous cannulation or change of site . Donors who are not able to hold the mercury column up to 30 mmHg for a period of at least 20 seconds would be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate analgesic efficacy of valsalva procedure in attenuating the needle puncture pain in first time non-remunerated voluntary plateletphereis DonorsTimepoint: 1 hr after platlet donation | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To assess anxiety status of platelet donors 2. To compare pain severity between male and female donors Timepoint: 1 hr after platlet donation | — |
Countries
India
Contacts
Public ContactSanjay Kumar
Sanjay Gandhi Post Graduate Institute of Medical Sciences
Outcome results
None listed